Next earnings date: 27 Oct 2025
BriaCell Therapeutics Corp. – NASDAQ:BCTX
Founder-led company
BriaCell Therapeutics Corp. stock price today
$0.71
+0.15
+27.74%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 26 minutes
BriaCell Therapeutics Corp. stock price monthly change
-37.12%
month
BriaCell Therapeutics Corp. stock price quarterly change
-37.12%
quarter
BriaCell Therapeutics Corp. stock price yearly change
-89.41%
year
BriaCell Therapeutics Corp. key metrics
Market Cap | 25.63M |
Enterprise value | N/A |
P/E | -13.56 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | -85.43 |
PEG ratio | N/A |
EPS | -1.03 |
Revenue | N/A |
EBITDA | -31.88M |
Income | -16.43M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeBriaCell Therapeutics Corp. stock price history
BriaCell Therapeutics Corp. stock forecast
BriaCell Therapeutics Corp. financial statements
| Apr 2023 | 0 | -4.36M | |
|---|---|---|---|
| Jul 2023 | 0 | -2.41M | |
| Jan 2024 | 0 | -11.35M | |
| Apr 2024 | 0 | 1.71M |
| 2024-10-28 | -0.52 | -0.07 |
|---|
| Apr 2023 | 29721868 | 35.61M | 119.82% |
|---|---|---|---|
| Jul 2023 | 27163577 | 30.94M | 113.91% |
| Jan 2024 | 12156285 | 20.42M | 168% |
| Apr 2024 | 6185697 | 12.40M | 200.48% |
| Apr 2023 | -5.33M | 0 | 1.59K |
|---|---|---|---|
| Jul 2023 | -10.91M | 0 | 4M |
| Jan 2024 | -7.44M | 0 | 0 |
| Apr 2024 | -4.96M | -220.84K | 0 |
BriaCell Therapeutics Corp. alternative data
| Aug 2023 | 5 |
|---|---|
| Sep 2023 | 5 |
| Oct 2023 | 5 |
| Nov 2023 | 5 |
| Dec 2023 | 16 |
| Jan 2024 | 16 |
| Feb 2024 | 16 |
| Mar 2024 | 16 |
| Apr 2024 | 16 |
| May 2024 | 16 |
| Jun 2024 | 16 |
| Jul 2024 | 16 |
BriaCell Therapeutics Corp. other data
15.95%
-1.21%
of BCTX is owned by hedge funds
2.47M
-188.52K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| May 2024 | 1805870 | 0 |
| Insider | Compensation |
|---|---|
Dr. Charles Louis Wiseman FACP, M.D. (1946) Founder, Principal Advisor & Member of Scientific Advisory Board | $241,140 |
Dr. William V. Williams M.D. (1956) Chief Executive Officer, Pres & Director | $218,000 |
Mr. Gadi Levin B.Com., C.A., CPA, M.B.A., MBA (1973) Chief Financial Officer & Corporation Sec. | $114,280 |
-
What's the price of BriaCell Therapeutics Corp. stock today?
One share of BriaCell Therapeutics Corp. stock can currently be purchased for approximately $0.71.
-
When is BriaCell Therapeutics Corp.'s next earnings date?
BriaCell Therapeutics Corp. is estimated to report earnings on Monday, 27 Oct 2025.
-
Does BriaCell Therapeutics Corp. pay dividends?
No, BriaCell Therapeutics Corp. does not pay dividends.
-
How much money does BriaCell Therapeutics Corp. make?
BriaCell Therapeutics Corp. has a market capitalization of 25.63M. BriaCell Therapeutics Corp. made a loss 4.79M US dollars in net income (profit) last year or -$0.07 on an earnings per share basis.
-
What is BriaCell Therapeutics Corp.'s stock symbol?
BriaCell Therapeutics Corp. is traded on the NASDAQ under the ticker symbol "BCTX".
-
What is BriaCell Therapeutics Corp.'s primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of BriaCell Therapeutics Corp.?
Shares of BriaCell Therapeutics Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are BriaCell Therapeutics Corp.'s key executives?
BriaCell Therapeutics Corp.'s management team includes the following people:
- Dr. Charles Louis Wiseman FACP, M.D. Founder, Principal Advisor & Member of Scientific Advisory Board(age: 79, pay: $241,140)
- Dr. William V. Williams M.D. Chief Executive Officer, Pres & Director(age: 69, pay: $218,000)
- Mr. Gadi Levin B.Com., C.A., CPA, M.B.A., MBA Chief Financial Officer & Corporation Sec.(age: 52, pay: $114,280)
-
Is BriaCell Therapeutics Corp. founder-led company?
Yes, BriaCell Therapeutics Corp. is a company led by its founder Dr. Charles Louis Wiseman FACP, M.D..
-
How many employees does BriaCell Therapeutics Corp. have?
As Jul 2024, BriaCell Therapeutics Corp. employs 16 workers.
-
When BriaCell Therapeutics Corp. went public?
BriaCell Therapeutics Corp. is publicly traded company for more then 13 years since IPO on 14 Mar 2012.
-
What is BriaCell Therapeutics Corp.'s official website?
The official website for BriaCell Therapeutics Corp. is briacell.com.
-
Where are BriaCell Therapeutics Corp.'s headquarters?
BriaCell Therapeutics Corp. is headquartered at Bellevue Centre, West Vancouver, BC.
-
How can i contact BriaCell Therapeutics Corp.?
BriaCell Therapeutics Corp.'s mailing address is Bellevue Centre, West Vancouver, BC and company can be reached via phone at +60 4 921 1810.
BriaCell Therapeutics Corp. company profile:
BriaCell Therapeutics Corp.
briacell.comExchange:
NASDAQ
Full time employees:
16
Industry:
Biotechnology
Sector:
Healthcare
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
Bellevue Centre
West Vancouver, BC V7T 2X1
West Vancouver, BC V7T 2X1
CIK: 0001610820
ISIN: CA1079301091
CUSIP: 10778Y302
